Robert Biesen
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.
Journal: EULAR rheumatology open
Published: August 01, 2026
Cytokine-mediated activation of kidney-infiltrating CD8+ T cells enables their contribution to inflammation in human lupus nephritis.
Journal: Science translational medicine
Published: July 08, 2026
Blinatumomab in refractory SLE-associated immune thrombocytopenia.
Journal: Annals of the rheumatic diseases
Published: July 01, 2026
Systemic sclerosis triggered by bleomycin: a 5-year follow-up.
Journal: EULAR rheumatology open
Published: June 29, 2026
BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease.
Journal: Rheumatology (Oxford, England)
Published: June 23, 2026
Single-cell Unperturbed Activation Profiling by mass cytometry captures in vivo immune signaling in SLE.
Journal: Frontiers in immunology
Published: March 31, 2026
Increased Type I Interferon Activity with Concurrent Plasmablast Expansion Identifies Systemic Lupus Erythematosus Patients with Poor Outcomes.
Journal: International journal of molecular sciences
Published: February 28, 2026
When Infection Leaves Its Mark: Calcinosis in Systemic Sclerosis.
Journal: The Journal of rheumatology
Published: February 15, 2026
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Last Updated: 09/26/2026